Androgen hormone action in prostatic carcinogenesis: Stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis

Carcinogenesis

Volumn 33, Issue 7, 2012, Pages 1391-1398

  Ricke, Emily A ^a   Williams, Karin ^b   Lee, Yi Fen ^b   Couto, Suzana ^c   Wang, Yuzhuo ^d   Hayward, Simon W ^e   Cunha, Gerald R ^f   Ricke, William A ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c GENENTECH INC   (United States)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 2; KERATINOCYTE GROWTH FACTOR; SCATTER FACTOR;

ANDROGEN DEPRIVATION THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CASTRATION; CELL GROWTH; CONTROLLED STUDY; EMBRYO; EPITHELIUM CELL; GENE CONTROL; GENE DELETION; GENE EXPRESSION; HORMONE ACTION; HORMONE DEPENDENCE; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; MALE; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOGENESIS; PROTEIN SECRETION; STROMA CELL; TUMOR MICROENVIRONMENT;

ANDROGEN ANTAGONISTS; ANDROGENS; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; IMMUNOHISTOCHEMISTRY; MALE; MICE; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84865189295     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs153     Document Type: Article

References (36)

1. American Cancer Society. Cancer Facts & Figures 2010. Altanta, GA: American Cancer Society pp. 4.
2. Belanger,A. et al. (1994) Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J. Clin. Endocrinol. Metab., 79, 1086-1090.
3. Wilson,J.D. (1980) The pathogenesis of benign prostatic hyperplasia. Am. J. Med., 68, 745-756.
4. Ho,S.M. et al. (1993) Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats. Cancer Res., 53, 528-532.
5. Leav,I. et al. (1988) Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. J. Natl Cancer Inst., 80, 1045-1053.
6. Ricke,W.A. et al. (2006) Steroid hormones stimulate human prostate cancer progression and metastasis. Int. J. Cancer, 118, 2123-2131.
7. Wang,Y. et al. (2000) Hormonal carcinogenesis of the Rb-knockout mouse prostate. Cancer Res., 60, 6008-6017.
8. Wang,Y. et al. (2001) A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res., 61, 6064-6072.
9. Noble,R.L. (1977) The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res., 37, 1929-1933.
10. Cunha,G.R. et al. (1978) The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wildtype and androgen-insensitive (Tfm) mice. J. Exp. Zool., 205, 181-193.
11. Donjacour,A.A. et al. (1993) Assessment of prostatic protein secretion in tissue recombinants made of urogenital sinus mesenchyme and urothelium from normal or androgen-insensitive mice. Endocrinology, 131, 2342-2350.
12. Chen,C.D. et al. (2004) Molecular determinants of resistance to antiandrogen therapy. Nat. Med., 10, 33-39.
13. Gao,J. et al. (1998) Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells. Cancer Res., 58, 3299-3306.
14. Stanbrough,M. et al. (2001) Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc. Natl Acad. Sci. USA, 98, 10823-10828.
15. Couto,S.S. et al. (2009) Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer. Differentiation, 77, 103-111.
16. Cunha,G.R. et al. (1979) The importance of stroma in morphogenesis and functional activity of urogenital epithelium. In Vitro, 15, 50-71.
17. Hayward,S.W. et al. (1995) Establishment and characterization of an immortalized but non-tumorigenic human prostate epithelial cell line: BPH-1. In Vitro, 31A, 14-24.
18. Niu,Y. et al. (2008) Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc. Natl Acad. Sci. USA, 105, 12182-12187.
19. Wu,C.T. et al. (2007) Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc. Natl Acad. Sci. USA, 104, 12679-12684.
20. Kurita,T. et al. (2001) Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system. Cell Death Differ., 8, 192-200.
21. Ricke,W.A. et al. (2008) Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J., 22, 1512-1520.
22. Hayward,S.W. et al. (2001) Malignant transformation in a nontumorigenic human prostatic epithelial cell line. Cancer Res., 61, 8135-8142.
23. Ellwood-Yen,K. et al. (2003) Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell, 4, 223-238.
24. Wang,S. et al. (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell, 4, 209-221.
25. Gingrich,J.R. et al. (1997) Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res., 57, 4687-4691.
26. Tran,C. et al. (2009) Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science, 324, 787-790.
27. Olapade-Olaopa,E.O. et al. (1999) Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma. Clin. Cancer Res., 5, 569-576.
28. Henshall,S.M. et al. (2001) Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Cancer Res., 61, 423-427.
29. Phillips,J.L. et al. (2001) The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res., 61, 8143-8149.
30. Niu,Y. et al. (2008) Targeting the stromal androgen receptor in primary prostate tumors at earlier stages. Proc. Natl Acad. Sci. USA, 105, 12188-12193.
31. Bello,D. et al. (1997) Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis, 18, 1215-1223.
32. Acevedo,V.D. et al. (2007) Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell, 12, 559-571.
33. Lawson,D.A. et al. (2010) Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc. Natl Acad. Sci. USA, 107, 2610-2615.
34. Memarzadeh,S. et al. (2007) Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell, 12, 572-585.
35. Bhowmick,N.A. et al. (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science, 303, 848-851.
36. Olumi,A.F. et al. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res., 59, 5002-5011.